Clinical Trials Directory

Trials / Unknown

UnknownNCT00493493

Pore Excision, Curettage, and Injection of Cymetra for Pilonidal Disease

Pore Excision, Curettage, and Injection of a Tissue Scaffold as Treatment for Pilonidal Disease

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Matino, James, M.D. · Individual
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Chronic pilonidal disease is a common problem with no ideal treatment. This is a prospective study that will evaluate the results of surgical pore excision, curettage, and injection of a regenerative tissue matrix, Cymetra, on patients with chronic pilonidal disease.

Detailed description

In addition, the study will evaluate the credibility and reproducibility of results within other surgeons trained to perform the procedure. Data collection will focus on post-operative wound failure, infection ratwes, analgesic requirements, time lost from work or school, wound care requirements, and 6 month recurrence rates. These outcomes will be compared to outcomes using conventional pilonidal surgical intervention using published data.

Conditions

Interventions

TypeNameDescription
PROCEDUREsurgery (Pore Excision, Curettage, and Injection of Cymetra)

Timeline

Start date
2007-01-01
Completion
2008-06-01
First posted
2007-06-28
Last updated
2007-06-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00493493. Inclusion in this directory is not an endorsement.